These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23598698)

  • 1. Nanoporous silica coatings as a drug delivery system for ciprofloxacin: outcome of variable release rates in the infected middle ear of rabbits.
    Hesse D; Ehlert N; Lüenhop T; Smoczek A; Glage S; Behrens P; Müller PP; Esser KH; Lenarz T; Stieve M; Bleich A; Prenzler NK
    Otol Neurotol; 2013 Aug; 34(6):1138-45. PubMed ID: 23598698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of nanoporous silica coatings on middle ear prostheses as a delivery system for antibiotics: an animal study in rabbits.
    Lensing R; Bleich A; Smoczek A; Glage S; Ehlert N; Luessenhop T; Behrens P; Müller PP; Kietzmann M; Stieve M
    Acta Biomater; 2013 Jan; 9(1):4815-25. PubMed ID: 22906623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocompatibility of silver containing silica films on Bioverit® II middle ear prostheses in rabbits.
    Duda F; Bradel S; Bleich A; Abendroth P; Heemeier T; Ehlert N; Behrens P; Esser KH; Lenarz T; Brandes G; Prenzler NK
    J Biomater Appl; 2015 Jul; 30(1):17-29. PubMed ID: 25659947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Layered double hydroxides as efficient drug delivery system of ciprofloxacin in the middle ear: an animal study in rabbits.
    Hesse D; Badar M; Bleich A; Smoczek A; Glage S; Kieke M; Behrens P; Müller PP; Esser KH; Stieve M; Prenzler NK
    J Mater Sci Mater Med; 2013 Jan; 24(1):129-36. PubMed ID: 23053799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of sustained release ciprofloxacin microspheres against device-associated Pseudomonas aeruginosa biofilm infection in a rabbit peritoneal model.
    Owusu-Ababio G; Rogers JA; Morck DW; Olson ME
    J Med Microbiol; 1995 Nov; 43(5):368-76. PubMed ID: 7563002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment.
    Mehanna MM; Elmaradny HA; Samaha MW
    Drug Dev Ind Pharm; 2010 Jan; 36(1):108-18. PubMed ID: 19656004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free Bioverit II implants coated with a nanoporous silica layer in a mouse ear model-- a histological study.
    Vogt JC; Brandes G; Ehlert N; Behrens P; Nolte I; Mueller PP; Lenarz T; Stieve M
    J Biomater Appl; 2009 Aug; 24(2):175-91. PubMed ID: 18987019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological evaluation of novel ossicular chain replacement prostheses: an animal study in rabbits.
    Turck C; Brandes G; Krueger I; Behrens P; Mojallal H; Lenarz T; Stieve M
    Acta Otolaryngol; 2007 Aug; 127(8):801-8. PubMed ID: 17729180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Local treatment of purulent chronic otitis media with ciprofloxacin].
    Podoshin L; Brodzki A; Fradis M; Ben-David J; Larboni J; Srugo I
    Harefuah; 1998 Jan; 134(1):32-6, 78. PubMed ID: 9517277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance and pharmacokinetics of a ciprofloxacin-coated sinus stent in a preclinical model.
    Cho DY; Hoffman K; Skinner D; Mackey C; Lim DJ; Alexander GC; Bae CY; Han DK; Jun HW; Woodworth BA
    Int Forum Allergy Rhinol; 2017 Apr; 7(4):352-358. PubMed ID: 27992118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant.
    Koort JK; Makinen TJ; Suokas E; Veiranto M; Jalava J; Tormala P; Aro HT
    Acta Orthop; 2008 Apr; 79(2):295-301. PubMed ID: 18484258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative trial of different anti-bacterial combinations with propolis and ciprofloxacin on Pseudomonas keratitis in rabbits.
    Onlen Y; Tamer C; Oksuz H; Duran N; Altug ME; Yakan S
    Microbiol Res; 2007; 162(1):62-8. PubMed ID: 16904302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local treatment of experimental Pseudomonas aeruginosa osteomyelitis with a biodegradable dilactide polymer releasing ciprofloxacin.
    Kanellakopoulou K; Thivaios GC; Kolia M; Dontas I; Nakopoulou L; Dounis E; Giamarellos-Bourboulis EJ; Andreopoulos A; Karagiannakos P; Giamarellou H
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2335-9. PubMed ID: 18411320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesoporous silica films as a novel biomaterial: applications in the middle ear.
    Ehlert N; Mueller PP; Stieve M; Lenarz T; Behrens P
    Chem Soc Rev; 2013 May; 42(9):3847-61. PubMed ID: 23525266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suboptimal ciprofloxacin dosing as a potential cause of decreased Pseudomonas aeruginosa susceptibility in children with cystic fibrosis.
    Guillot E; Sermet I; Ferroni A; Chhun S; Pons G; Zahar JR; Jullien V
    Pharmacotherapy; 2010 Dec; 30(12):1252-8. PubMed ID: 21114393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled ciprofloxacin for chronic airways infections caused by Pseudomonas aeruginosa.
    Antonela Antoniu S
    Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1439-46. PubMed ID: 23253321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral necrotising fasciitis of the ocular adnexa secondary to Pseudomonas aeruginosa septicaemia in a HIV-positive child.
    Scheepers MA; Keel S; Michaelides M
    Orbit; 2010 Feb; 29(1):63-4. PubMed ID: 20302416
    [No Abstract]   [Full Text] [Related]  

  • 18. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
    Rahman A; Rizwan S; Waycaster C; Wall GM
    Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined application of ciprofloxacin and tobramycin on mutant selective windows of ciprofloxacin against Pseudomonas aeruginosa].
    Liu MT; Sheng MY; Zhang Y; Li Y
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(20):1427-31. PubMed ID: 21756818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.